Apadenoson Uses, Dosage, Side Effects and more
Apadenoson is a selective A2a adenosine receptor agonist designed for use as a pharmacologic stress agent in cardiac perfusion imaging studies. It is developed by Bristol-Myers Squibb and is in phase II of clinical trials.
| Attribute | Details |
|---|---|
| Trade Name | Apadenoson |
| Generic | Apadenoson |
| Apadenoson Other Names | Apadenoson |
| Type | |
| Formula | C23H30N6O6 |
| Weight | Average: 486.529 Monoisotopic: 486.22268271 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in cardiovascular disorders and inflammatory disorders (unspecified).
How Apadenoson works
BMS068645 is designed to selectively stimulate the A2a adenosine receptor responsible for coronary vasodilation. Research to date suggests that this compound could potentially reduce or eliminate side effects associated with currently available pharmacologic stress agents that are not selective for the A2a adenosine receptor.
